Technology in Cancer Research & Treatment (Oct 2022)

Depicting the Implication of miR-378a in Cancers

  • Yuelan Qin BM,
  • Renba Liang MD, PhD,
  • Pingan Lu BS,
  • Lin Lai MD, PhD,
  • Xiaodong Zhu MD, PhD

DOI
https://doi.org/10.1177/15330338221134385
Journal volume & issue
Vol. 21

Abstract

Read online

MicroRNA-378a (miR-378a), including miR-378a-3p and miR-378a-5p, are encoded in PPARGC1B gene. miR-378a is essential for tumorigenesis and is an independent prognostic biomarker for various malignant tumors. Aberrant expression of miR-378a affects several physiological and pathological processes, including proliferation, apoptosis, tumorigenesis, cancer invasion, metastasis, and therapeutic resistance. Interestingly, miR-378a has a dual functional role in either promoting or inhibiting tumorigenesis, independent of the cancer type. In this review, we comprehensively summarized the role and regulatory mechanisms of miR-378a in cancer development, hoping to provide a direction for its potential use in cancer therapy.